期刊文献+

连续性肾脏替代治疗对毛细血管渗漏综合征患者炎性指标的影响 被引量:2

Influence of continuous renal replacement therapy on inflammatory indexes of patients with capillary leakage syndrome
下载PDF
导出
摘要 目的:探讨连续性肾脏替代治疗(CRRT)对毛细血管渗漏综合征(CLS)患者炎性指标的影响。方法:选取2010年1月~2012年11月于本院进行常规治疗加CRRT治疗的20例CLS患者为观察组,而同期未进行CRRT治疗的20例患者为对照组,比较两组患者治疗前与治疗后1、3d的血清促炎因子和抗炎因子水平。结果:观察组治疗后1、3d的血清促炎因子和抗炎因子水平改善幅度均大于对照组,差异有统计学意义(P均<0.05)。结论:CRRT可有效改善CLS患者的炎性状态,对改善患者的预后发挥着积极的作用。 Objective: To study the influence of continuous renal replacement therapy (CRRT)on inflammatory indexes of patients with capillary leakage syndrome(CLS). Methods: A total of 20 patients with CLS who were treated with routine treatment and CRRT in our hospital from January 2010 to November 2019 were selected as observation group,and 20 patients without CRRT at the same time were selected as control group, then the serum inflammatory factors and anti-inflammatory factors of two groups before and after the treatment at first and third day were compared. Results:Serum inflammatory factors and anti-inflammatory factors of observation group after the treatment at first and third day were all more significantly improved than those of control group(P〈0.05). Conc[usions:CRRT can effectively improve the inflammatory state of patients with CLS, so it plays an active role in improving the prognosis of patients.
作者 龙军成
出处 《海南医学院学报》 CAS 2013年第3期359-361,共3页 Journal of Hainan Medical University
基金 中国高校医学期刊临床专项资金项目(112210559)~~
关键词 连续性肾脏替代治疗(CRRT) 毛细血管渗漏综合征(CLS) 促炎因子 抗炎因子 CRRT CLS Inflammatory factors Anti-inflammatory factors
  • 相关文献

参考文献6

二级参考文献42

  • 1王今达,王宝恩.多脏器功能失常综合征(MODS)病情分期诊断及严重程度评分标准(经庐山’95全国危重病急救医学学术会讨论通过)[J].中国危重病急救医学,1995,7(6):346-347. 被引量:1421
  • 2陈绍礼,白长学.全身炎性反应综合征相关问题研究新进展[J].医学综述,2006,12(15):948-950. 被引量:17
  • 3[21]Hickey E,Karamlou T,You J,et al.Effects of circuit miniaturization in reducing inflammatory response to infant eardiopulmongry bypass by elimination of allogeneic blood products[J].Ann Thorac Surg,2006,81(6):S2367-2372.
  • 4[22]Miyaji K,Miyamoto T,Kohira S,et al.Miniaturized cardiopulmonary bypass system in neonates and sInau infants[J].Interact Cardiovasc Thorac Surg,2008,7(1):75-78.
  • 5[23]Jessen ME.Pro:Heparin-coated circuits should be used for cardiopulmonary bypass[J].Anosth Analg,2006,103(6):1365-1369.
  • 6[25]Liu J,Ji B,Long C.et al.Comparative effectiveness of methylprednisolone and zero-balance ultrafiltration on inflammatory response after pediatric cardiopulmonary bypass[J].Arfif Organs,2007,31(7):571-575.
  • 7[1]Rothenburgcr M,Soeparwata R,Deng MC,et al.Prediction of clinical outcome after cardiac surgery:the role of cytokines,endotoxin,and anti-endotoxin core antibodies[J].Shock,2001,16(Suppl 1):44 -50
  • 8[2]Lequeier LL,Nikaidoh H,Leonard SR,et al.Preoperative and postoperative endotoxemia in children with eongenital heart disease[J].Chest,2000,117(6):1706-1712.
  • 9[3]Abrahamov D,Erez E,Tamariz M,et al.Plasma vascular endothelial growth factor level is a predictor of the severity of postoperative capillary leak syndrome in neonates undergoing cardiopuimonacy bypass[J].Pediatr Surg Int,2002,18(1):54 -59.
  • 10[4]Zhang S,Wang S,Yao S.Evidence for Development of Capillary leak Syndrome Associated with Cardiopulmonary Bypass in Pediatric Patients with the Homozygous CAA Null Phenotype[J].Anesthesiology,2004,100 (6):1387-1393.

共引文献58

同被引文献27

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部